Ajanta Pharma in a communication to stock exchanges informed that its board will meet next week on Tuesday, 10th May, 2022 to consider financial results of the company and issue of bonus shares subject to approval by the shareholders of the company.
Bonus shares are fully paid additional shares issued by a company to its existing shareholders.
Ajanta Pharma shares were trading 5% higher at ₹1,804 apiece on the BSE in Monday's session. The pharma stock is down more than 19% in 2022 (YTD) so far.
Established in 1973 and headquartered in Mumbai-India, Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacture and marketing of finished dosages in domestic and international markets.